Human albumin solution resuscitation in severe sepsis and septic shock

Media, War and Conflict

Volumn 14, Issue 1, 2013, Pages 45-52

  Leitch, Andrew ^a   Craig, Gordon ^b   Sadler, Paul ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b PORTSMOUTH HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

albumins; meta analysis; plasma substitutes; resuscitation; sepsis

Indexed keywords

EID: 84916877758     PISSN: 17506352     EISSN: 17506360     Source Type: Journal    
DOI: 10.1177/175114371301400110     Document Type: Review

References (53)

1. Martin GS. Pharmacological aspects of albumin as a niche product in the intensive care unit. Crit Care Med. 2005 ; 33: 1667-69
2. Delaney AP, Dan A, McCaffrey J, Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: A systematic review and meta-analysis. Crit Care Med. 2011 ; 39: 386-391
3. Cui JY, Xu HL, Wang AT, et al. Influence of albumin as a resuscitation fluid on the prognosis of patients with sepsis: a meta-analysis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue/Chinese Crit Care Med. 2012 ; 24: 18-23
4. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2007 ; 34: 17-60
5. Levy MM, Macias WL, Vincent J-L, et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med. 2005 ; 33: 2194-201
6. Ospina-Tascon G, Neves AP, Occhipinti G, et al. Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med. 2010 ; 36: 949-55
7. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004 ; 350: 2247-56
8. Rackow EC, Falk JL, Fein IA, et al. Fluid resuscitation in circulatory shock: A comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med. 1983 ; 11: 839-50
9. Metildi L, Shackford S, Virgilio R, Peters R. Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surg Gyn Obstet. 1984 ; 158: 207-12
10. Trof RJ, Sukul SP, Twisk JWR, et al. Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia. Intensive Care Med. 2010 ; 36: 697-701
11. Payen D. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg. 2011 ; 112: 17-18
12. Wiedermann CJ. Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med. 2008 ; 8: 1-8
13. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012 ; 367: 124-34
14. Quinlan GJ, Martin GS, Evans TW. Albumin: Biochemical properties and therapeutic potential. Hepatology. 2005 ; 41: 1211-19
15. Horsey PJ. The Cochrane 1998 Albumin Review - not all it was cracked up to be. Eur J Anaesthesiol. 2002 ; 19: 701-04
16. Matejtschuk P, Dash CH, Gascoigne EW. Production of human albumin solution: A continually developing colloid. Br J Anaesth. 2000 ; 85: 887-95
17. Thyer J, Unal A, Thomas P, et al. Prion removal capacity of chromatographic and ethanol precipitation steps used in the production of albumin and immunoglobulins. Vox Sang. 2006 ; 91: 292-300
18. Alibaba.com. Human Albumin Manufacturers, Suppliers and Exporters. Available from: http://www.alibaba.com/products/human-albumin/ - - - S.html?tracelog=supplierdetails-9708 Accessed 28 July 2011.
19. Albumin.. London: BMJ Publishing Group ; 2011 :
20. Michel CC, Phillips ME. Steady-state fluid filtration at different capillary pressures in perfused frog mesenteric capillaries. J Physiol. 1987 ; 388: 421-35
21. Becker BF, Chappell D, Bruegger D, et al. Therapeutic strategies targeting the endothelial glycocalyx: Acute deficits, but great potential. Cardiovasc Res. 2010 ; 87: 300-10
22. Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 2010 ; 87: 198-210
23. Jacob M, Bruegger D, Rehm M, et al. The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res. 2007 ; 73: 575-86
24. Steppan J, Hofer S, Funke B, et al. Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalyx. J Surg Res. 2011 ; 112: 1289-95
25. Margarson MP, Soni NC. Effects of albumin supplementation on microvascular permeability in septic patients. J Appl Physiol. 2002 ; 92: 2139-45
26. Evidence-based colloid use in the critically ill: American Thoracic Society consensus statement. Am J Respir Crit Care Med. 2004 ; 170: 1247-59
27. Nathan C, Xie Q, Halbwachs-Mecarelli L, Jin W. Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin). J Cell Biol. 1993 ; 122: 243-56
28. Rhee P, Wang D, Ruff P, et al. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med. 2000 ; 28: 74-78
29. Zhang W-J, Frei B. Albumin selectively inhibits TNF -induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res. 2002 ; 55: 820-29
30. Cantin AM, Paquette B, Richter M, Larivee P. Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation. Am J Respir Crit Care Med. 2000 ; 162: 1539-46
31. Meziani F, Kremer H, Tesse A, et al. Human serum albumin improves arterial dysfunction during early resuscitation in mouse endotoxic model via reduced oxidative and nitrosative stresses. Am J Pathol. 2007 ; 171: 1753-61
32. Quinlan GJ, Mumby S, Martin GS, et al. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med. 2004 ; 32: 755-59
33. Tokunaga C, Bateman RM, Boyd J, et al. Albumin resuscitation improves ventricular contractility and myocardial tissue oxygenation in rat endotoxemia. Crit Care Med. 2007 ; 35: 1341-47
34. Shafer SL. Editor's note: Notices of retraction. Anesth Analg. 2011 ; 112: 1246-47
35. Higgins JPT, Green S Cochrane Handbook for Systematic Reviews of Interventions.. The Cochrane Collaboration ; 2011 :
36. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Copenhagen; 2011.
37. Falk J, Rackow E, Astiz M, Weil M. Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol. 1988 ; 28: 412-15
38. Rackow EC, Mecher C, Astiz ME, et al. Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion. Crit Care Med. 1989 ; 17: 394-98
39. Ernest D, Belzberg A, Dodek P. Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med. 1999 ; 27: 46-50
40. Veneman TF, Nijhuis J Oude, Woittiez AJ. Human albumin and starch administration in critically ill patients: a prospective randomized clinical trial. Wien Klin Wochenschr. 2004 ; 116: 305-09
41. Palumbo D, Servillo G, D'Amato L, et al. The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anestesiol. 2006 ; 72: 655-64
42. Friedman G, Jankowski S, Shahla M, et al. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients. J Clin Anesth. 2008 ; 20: 528-33
43. Dolecek M, Svoboda P, Kantorová I, et al. Therapeutic influence of 20 % albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. Hepatogastroenterology. 2009 ; 56: 1622-28
44. Van der Heijden M, Verheij J, van Nieuw Amerongen GP, Groeneveld ABJ. Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med. 2009 ; 37: 1275-81
45. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 2011 ; 37: 86-96
46. Kleppe CG. Congress of the European Society of Intensive Care Medicine Berlin 2011: Hot Topics Session. Neth J Crit Care. 2012 ; 16: 63-64
47. GattinoniLCaironiP. The AlbIOS Study. Newsletter 36. http://www.negrisud.it/albios/news/newsletter-albios-36.pdf Accessed 28 March 2012.
48. Finfer S, Liu B, Taylor C, et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care. 2010 ; 14: R185
49. Vincent J-L, Navickis RJ, Wilkes MM. Morbidity in hospitalized patients receiving human albumin: A meta-analysis of randomized, controlled trials. Crit Care Med. 2004 ; 32: 2029-38
50. Kremer H, Baron-Menguy C, Tesse A, et al. Human serum albumin improves endothelial dysfunction and survival during experimental endotoxemia: Concentration-dependent properties. Crit Care Med. 2011 ; 39: 1414-22
51. Bracht H, Georgieff M, Matejovic M, Radermacher P. Human serum albumin as a resuscitation fluid: Less SAFE than presumed?. Crit Care Med. 2011 ; 39: 1584-85
52. Halliwell B. The antioxidant paradox. Lancet. 2000 ; 355: 1179
53. Bar-Or D, Bar-Or R, Rael LT, et al. Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit Care Med. 2005 ; 33: 1638-41